Unum Therapeutics Inc (NASDAQ:UMRX)

0.52
Delayed Data
As of May 22
 +0.0059 / +1.15%
Today’s Change
0.30
Today|||52-Week Range
3.65
-27.80%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-6.6M-18.1M-25.5M-34.5M
 
 
 
 
 
Depreciation179.0K830.0K1.2M1.3M
 
 
 
 
 
Total Other Cash Flow248.0K977.0K1.4M2.9M
 
 
 
 
 
Funds From Operations-6.2M-16.3M-23.0M-30.3M
 
 
 
 
 
Funds From/For Other Operating Expenses-23.9M2.3M2.9M2.2M
 
 
 
 
 
Net Cash Flow - Operating Activities17.7M-18.6M-25.8M-32.5M
 
 
 
 
 
 
InvestingIncrease In Investments0.00-55.2M-6.5M-47.7M
 
 
 
 
Decrease In Investments0.0028.0M21.0M37.7M
 
 
 
 
Capital Expenditures-2.0M-3.3M-912.0K-549.0K
 
 
 
 
 
Net Cash Flow Investing-2.0M-30.5M13.6M-10.5M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale70.8M0.0060.0K609.0K
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.00--71.8M
 
 
Other Uses - Financing0.000.00789.0K2.1M
 
 
 
Net Cash Flow - Financing70.8M-40.0K-729.0K70.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash86.5M-49.2M-13.0M27.3M